|
Mark P. Mattson answers a
few questions about this month's fast breaking paper in the field of
Neuroscience & Behavior.
From
•>>August 2005
Field:
Neuroscience & Behavior
Article Title: Pathways towards and away from Alzheimer's disease
Authors: Mattson, MP
Journal: NATURE
Volume: 430
Page: 631-639
Year: AUG 5 2004
* NIA, Neurosci Lab, Intramural Res Program, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.
* NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.
* Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.
|
Why
do you think your paper is highly cited?
|

“My review article provides food for thought and action for scientists and clinicians interested in AD.”
|
|
Alzheimer's disease
(AD) is a devastating age-related disorder of progressive memory
impairment and behavioral disturbances that exacts a toll not
only on the patient, but also on his/her family and friends.
Rapid advances on multiple fronts—genetics, cell and molecular
biology, brain imaging, and epidemiology, among others—have
revealed some of the major abnormalities that result in the
dysfunction of synapses and the death of neurons in AD. This
paper is highly cited because it is a review article that
describes the current state of knowledge of the cellular and
molecular mechanisms of AD in the context of genes, aging, and
the environment. I attempted to write the article so that it was
concise and readable, yet inclusive of a range of findings and
issues concerning the cellular and molecular mechanisms of
neuronal dysfunction and death in AD, and preventative and
therapeutic approaches that have/will emerge from this research.
The history of AD research is a wonderful example of how
studying a disease can reveal previously unrecognized
physiological mechanisms, with the story of the secretases that
cleave the amyloid precursor protein and Notch1 being a prime
example. Human Notch1 is a modular, single-pass transmembrane
receptor that normally controls cellular differentiation in
hematopoetic including neurons. The complexity of this disease
encompasses an increasing number of disciplines, including
free-radical biology, regulation of cellular ion homeostasis and
energy metabolism, and immunology. My review article provides
food for thought and action for scientists and clinicians
interested in AD.
How
did you become involved in this research?
A series of developments in my research projects in
developmental neurobiology when I was a postdoc eventually led
to a strong interest in AD. At that time my colleagues and I
were providing evidence that neurotransmitters not only function
in synaptic transmission in the mature nervous system, but also
regulate the outgrowth and survival of neurons in the developing
brain. I had found that the neurotransmitter glutamate regulates
dendrite outgrowth and synaptogenesis in the developing
hippocampus (a brain region involved in learning and memory and
vulnerable in AD). However, excessive activation of glutamate
receptors could kill neurons, causing some changes in the
cytoskeleton of neurons that are similar to those seen in dying
neurons in the brains of AD patients. This led me to explore the
effects of amyloid beta-peptide (which forms amyloid plaques in
the brain in AD) on neurons, demonstrating toxic effects
mediated by oxidative stress and an impaired ability to regulate
calcium levels. We further showed that several different
neurotrophic factors can protect neurons from being damaged and
killed by glutamate and amyloid, and have been particularly
interested in elucidating signaling pathways that can prevent
amyloid production and deposition in the brain on the one hand,
and those that can protect neurons from being damaged by amyloid
on the other hand. This research has contributed to the
development of novel preventative and therapeutic strategies for
AD, including diets and drugs that protect neurons against the
damaging effects of glutamate and amyloid.
Mark P. Mattson, Ph.D.
Chief of the Laboratory of Neurosciences
Cellular and Molecular Neurosciences Section
National Institute on Aging Intramural Research Program
Gerontology Research Center
Baltimore, MD, USA
|
ESI Special Topics,
August 2005
Citing URL - http://www.esi-topics.com/fbp/2005/august05-MarkPMattson.html
|
|